Company

CLOVER HEALTH INVESTMENTS CORP

clov

In Q2 2026, Clover Health reported strong revenue growth of 56% driven by expanding Medicare Advantage membership to over 157,000 across five states and 203 counties. The company’s proprietary Clover Assistant platform underpins its strategy to improve clinical decision-making and member outcomes through wide physician networks and competitive cost-sharing plans. Notably, a court-ordered recalculation improved its CMS Star Ratings for PPO and HMO plans, potentially enhancing future reimbursement. However, rising general administrative expenses linked to membership expansion and ongoing regulatory risks including cybersecurity remain watchpoints. The company maintains solid liquidity with $443 million in cash and investments as of June 2026, supporting capacity to scale its integrated insurance and SaaS business model.

https://www.valye.com/news/clov-company-analysis-2026-08-10-clover-health-leverages-data-driven-platform-amid-medicare-advantage-expansio-236547Clover Health Leverages Data-Driven Platform Amid Medicare Advantage Expansion and Star Rating Recalibration